Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk

• Text
• PDF

Abstract

Authors

Shi Liu, Yongyin Li, Jian Sun

Genetic mechanism for the loss of PRAME in B cell lymphomas

• Text
• PDF

Abstract

Authors

Marek Mraz

Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply.

• Text
• PDF

Abstract

Authors

Katsuyoshi Takata, Christian Steidl

Concerns over functional experiments, interpretation, and required controls

• Text
• PDF

Abstract

Authors

Eddie C.Y. Wang, Ceri A. Fielding, Richard J. Stanton

Concerns over functional experiments, interpretation, and required controls. Reply.

• Text
• PDF

Abstract

Authors

Wan-Chen Hsieh, Shih-Yu Chen

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

• Text
• PDF

Abstract

Authors

George Kunos, Tony Jourdan, Joseph Tam

Does CB-1 in hepatic stellate cells contribute to liver fibrosis?

• Text
• PDF

Abstract

Authors

Sophie Lotersztajn, Ariane Mallat

Response to Kunos et al. and Lotersztajn and Mallat

• Text
• PDF

Abstract

Authors

Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel K. Elmquist, Philipp E. Scherer, Jay D. Horton

Difference in sensitivity between SARS-CoV-2–specific T cell assays in patients with underlying conditions

• Text
• PDF

Abstract

Authors

Rory D. de Vries, Marieke van der Heiden, Daryl Geers, Celine Imhof, Debbie van Baarle, RECOVAC-IR Collaborators

Difference in sensitivity between SARS-CoV-2–specific T cell assays in patients with underlying conditions. Reply.

• Text
• PDF

Abstract

Authors

Anthony T. Tan, Nina Le Bert, Antonio Bertoletti